2025-08-27
BioNTX Announces BIO CEO John Crowley as Featured Speaker at iC3® Life Science & Healthcare Innovation Summit
DALLAS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- BioNTX, the leading biotechnology and healthcare innovation trade organization in North Texas, is thrilled to announce that John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), will headline the 2025 iC3® Life Science & Healthcare Innovation Summit, scheduled for September 16–17 at the iconic Hilton Anatole in Dallas, Texas.Crowley—renowned for his pioneering leadership in rare disease drug development and his advocacy for patient-centered innovation—will set the stage for a bold forward-looking theme: "10 Years and Beyond." His keynote will help frame the national conversation on how today's breakthroughs are shaping tomorrow's biotech landscape."John F. Crowley's leadership at BIO marks a pivotal moment—not just for our region, but for the entire industry," said Kathleen M. Otto-Rosenblum, CEO of BioNTX. "His presence at iC3® signals that North Texas is at the heart of a nationwide innovation renaissance, where science, purpose, and opportunity converge to redefine what is possible."Now entering its second decade, the iC3® Summit—rooted in the formula Innovation = Capital × Collaboration × Commercialization—has become the region's premier platform. It brings together entrepreneurs, researchers, investors, and policymakers to co-create the future of life sciences and healthcare.This year's summit will spotlight Artificial Intelligence (AI) and its transformative impact across the biosciences—from precision medicine and AI-accelerated drug discovery to biomanufacturing and diagnostics.iC3® 2025 Summit Highlights Include:Featured Remarks by BIO CEO John CrowleyImmersive Panel Sessions — including, but not limited to:Full story available on Benzinga.com